Abbott Laboratories (ABT) Other financing activities (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Other financing activities data on file, last reported at $116.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities fell 59.58% year-over-year to $116.0 million; the trailing twelve-month figure through Mar 2026 stood at $225.0 million (up 47.06% YoY), and the FY2025 full-year result was $396.0 million, changed N/A from the prior year.
• Other financing activities rose to $116.0 million in Q1 2026, from $5.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $287.0 million in Q1 2025 to a low of -$239.0 million in Q4 2024.
• A 5-year average of $49.8 million and a median of $56.0 million in 2023 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities sank 802.94% in 2024 and soared 169.23% in 2025, its largest moves.
• Tracing ABT's Other financing activities over 5 years: stood at $41.0 million in 2022, then fell by 17.07% to $34.0 million in 2023, then slumped by 802.94% to -$239.0 million in 2024, then soared by 102.09% to $5.0 million in 2025, then jumped by 2220.0% to $116.0 million in 2026.
• Business Quant data shows ABT's Other financing activities at $116.0 million in Q1 2026, $5.0 million in Q4 2025, and $69.0 million in Q3 2025.